Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Scientific and Medical Equipment House (4014.SR) specializes in the manufacturing and distribution of medical devices and scientific instruments primarily in the Middle East region. The company's competitive position is bolstered by its established relationships with healthcare providers and a diverse product portfolio that includes diagnostic equipment and laboratory supplies.
The company generates revenue through direct sales of medical devices and laboratory supplies, complemented by consulting and maintenance services. Its competitive advantages include a strong distribution network and established brand recognition in the healthcare sector, allowing for pricing power in a fragmented market.
Changes in healthcare regulations impacting medical device approvals
Fluctuations in demand for diagnostic equipment due to public health trends
Competitive pricing strategies from major competitors
Technological advancements in medical devices
Technological disruption from new entrants in the medical device market
Regulatory changes affecting product compliance and market access
Increased competition from international medical device manufacturers
Pricing pressures from established players in the market
Moderate liquidity risk due to negative free cash flow
Potential pension obligations if applicable
moderate - the company's performance is somewhat tied to healthcare spending, which is influenced by GDP growth and consumer spending patterns.
Interest rates affect the company's financing costs for R&D and capital expenditures, potentially impacting its valuation multiples if rates rise significantly.
minimal - the company has a manageable debt/equity ratio of 0.35, indicating low reliance on external financing.
value - investors may be drawn to the stock due to its low price-to-sales ratio and potential for margin improvement.
moderate - the stock has shown a historical volatility consistent with the broader consumer cyclical sector.